BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31665554)

  • 41. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
    Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
    Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
    Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
    AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T1 signal intensity in the dentate nucleus after the administration of the macrocyclic gadolinium-based contrast agent gadoterate meglumine: an observational study.
    Ramalho J; Semelka RC; Cruz J; Morais T; Ramalho M
    Radiologia (Engl Ed); 2020 Oct; ():. PubMed ID: 33032813
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T1 Signal Measurements in Pediatric Brain: Findings after Multiple Exposures to Gadobenate Dimeglumine for Imaging of Nonneurologic Disease.
    Schneider GK; Stroeder J; Roditi G; Colosimo C; Armstrong P; Martucci M; Buecker A; Raczeck P
    AJNR Am J Neuroradiol; 2017 Sep; 38(9):1799-1806. PubMed ID: 28642266
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
    Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
    Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does renal function affect gadolinium deposition in the brain?
    Rahatli FK; Donmez FY; Kibaroglu S; Kesim C; Haberal KM; Turnaoglu H; Agildere AM
    Eur J Radiol; 2018 Jul; 104():33-37. PubMed ID: 29857863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Weekly enhanced T1-weighted MRI with Gadobutrol injections in MS patients: Is there a signal intensity increase in the dentate nucleus and the globus pallidus?
    Jaulent P; Hannoun S; Kocevar G; Rollot F; Durand-Dubief F; Vukusic S; Brisset JC; Sappey-Marinier D; Cotton F
    Eur J Radiol; 2018 Aug; 105():204-208. PubMed ID: 30017281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol.
    Stojanov DA; Aracki-Trenkic A; Vojinovic S; Benedeto-Stojanov D; Ljubisavljevic S
    Eur Radiol; 2016 Mar; 26(3):807-15. PubMed ID: 26105022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.
    Flood TF; Stence NV; Maloney JA; Mirsky DM
    Radiology; 2017 Jan; 282(1):222-228. PubMed ID: 27467467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.
    Roberts DR; Chatterjee AR; Yazdani M; Marebwa B; Brown T; Collins H; Bolles G; Jenrette JM; Nietert PJ; Zhu X
    AJNR Am J Neuroradiol; 2016 Dec; 37(12):2340-2347. PubMed ID: 27469211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol.
    Cao Y; Huang DQ; Shih G; Prince MR
    AJR Am J Roentgenol; 2016 Feb; 206(2):414-9. PubMed ID: 26700156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Exposure to Gadodiamide and Brain Irradiation on T
    Mallio CA; Parillo M; Zobel BB; Parizel PM; Quattrocchi CC
    J Magn Reson Imaging; 2020 Nov; 52(5):1525-1530. PubMed ID: 32478956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Gadolinium Deposition in the Brain After MR Arthrography.
    Kralik SF; Singhal KK; Frank MS; Ladd LM
    AJR Am J Roentgenol; 2018 Nov; 211(5):1063-1067. PubMed ID: 30106613
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive Speciation Analysis of Residual Gadolinium in Deep Cerebellar Nuclei in Rats Repeatedly Administered With Gadoterate Meglumine or Gadodiamide.
    Strzeminska I; Factor C; Jimenez-Lamana J; Lacomme S; Subirana MA; Le Coustumer P; Schaumlöffel D; Robert P; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2022 May; 57(5):283-292. PubMed ID: 35066532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dentate Nucleus Signal Intensity Changes in Children with Adrenoleukodystrophy in Comparison to Primary Brain Tumor with and without Radiotherapy after Gadobutrol Administration.
    Ozturk K; Nascene D
    J Neuroimaging; 2021 May; 31(3):602-608. PubMed ID: 33783925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of signal intensity changes in dentate nucleus and globus pallidus on magnetic resonance imaging after intrathecal gadolinium-based contrast agent administration.
    Asoğlu S; Kılınçer A; Özer H; Topaloğlu ÖF; Cebeci H
    Clin Imaging; 2024 May; 109():110140. PubMed ID: 38574605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Correlation between high signal intensity in cerebrum nucleus on unenhanced T
    Pei L; Xu J; Zhang M
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):487-491. PubMed ID: 29488714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Susceptibility-Weighted Imaging of the Pediatric Brain after Repeat Doses of Gadolinium-Based Contrast Agent.
    Ozturk K; Nascene D
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1136-1143. PubMed ID: 33888459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Is There Long-term Signal Intensity Increase in the Central Nervous System on T1-weighted Images after MR Imaging with the Hepatospecific Contrast Agent Gadoxetic Acid? A Cross-sectional Study in 91 Patients.
    Kahn J; Posch H; Steffen IG; Geisel D; Bauknecht C; Liebig T; Denecke T
    Radiology; 2017 Mar; 282(3):708-716. PubMed ID: 28076722
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain Irradiation and Gadobutrol Administration in Pediatric Patients with Brain Tumors: Effect on MRI Brain Signal Intensity.
    Tamrazi B; Liu CJ; Cen SY; Nelson MB; Dhall G; Nelson MD
    Radiology; 2018 Oct; 289(1):188-194. PubMed ID: 29989524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.